PA/NP - Hem Onc Outpatient Hackensack Meridian HealthPA/NP - Hem Onc OutpatientManahawkin, New JerseyFull timeThe posted rate of pay in this job posting is a reasonable good faith estimate of the minimum base pay for this role at the time of posting in accordance with the New Jersey Pay Transparency Act and does not reflect the full value of our market-competitive total rewards package. 4. Manages general medical and surgical conditions based on comprehensive knowledge of etiologies, risk factors, pathophysiology, and the indications and contraindications of pharmacologic agents and other treatment modalities.
Global Director, Clinical Project Management SystimmuneGlobal Director, Clinical Project ManagementPrinceton, NJ$180,000–$230,000 / yearIt specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development.
Associate Director, Clinical QA SystimmuneAssociate Director, Clinical QAPrinceton, NJ$150,000–$190,000 / yearThis position partners closely with Clinical Operations, Drug Safety/Pharmacovigilance, Regulatory Affairs, Biometrics, and external vendors to ensure the effective implementation of quality systems, proactive risk management, inspection readiness, and continuous improvement initiatives. The Associate Director serves as a key quality advisor across development programs and contributes to the advancement of a culture of quality and compliance throughout the organization.
Clinical Trial Physician, Cell Therapy, Medical Evidence Generation Bristol-Myers Squibb CoClinical Trial Physician, Cell Therapy, Medical Evidence GenerationPrinceton, NJ$253,390–$307,043 / yearThe CT MEG CTP will lead and participate in cross-functional matrix leadership teams focused on building these relationships and actively sourcing research concepts that address critical evidence gaps for early and late assets being developed in prioritized indications. This role will report to the Cell Therapy MEG Lead and will be expected to: Provide medical/clinical accountability and oversight for the various medical affairs-led sponsored studies (interventional and non-interventional), in alignment with the Integrated Evidence Plans (IEP) for the assets in company's portfolio.